Taken together, these data suggest IL-17RA is vital for controlling chronic inflammation in the gastric mucosa, ultimately reducing architectural changes in the tissue, reducing DNA damage, and slowing the development of H. pylori induced gastric cancer. Here, IL17RA is linked to gastric cancer.